Showing 491-500 of 2715 results for "".
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31146/Celiac Disease and Its Neurological Implications: Essential Insights for NeurologistsCeliac disease (CD), an autoimmune disorder triggered by gluten ingestion in genetically predisposed individuals, is traditionally recognized for its gastrointestinal manifestations such as chronic diarrhea, weight
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31140/Impact of SSRIs on Bone Health in Elderly Patients: Clinical InsightsRecent studies have raised concerns about the use of selective serotonin reuptake inhibitors (SSRIs) and their potential negative effects on bone health in older adults. These findings pose important considerations for neurologists
Sleep & Neurodevelopment
https://practicalneurology.com/diseases-diagnoses/sleep/sleep--neurodevelopment/30107/Sleep characterization in children may have a role in evaluation for risk of impaired development, behavior, mood, and self-regulation.Patient-Reported Outcome Measures in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/patient-reported-outcome-measures-in-neuromuscular-disorders/35531/Information gleaned from patient-reported outcome measures provides valuable insights into the effects of neuromuscular disorders on function and quality of life.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Mental Health and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/Assessing and addressing mental health in patients and care partners improves quality of life.Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/biomarkers-in-multiple-sclerosis/30195/Biomarkers have resulted from breakthrough treatments and, in turn, provide targets for more breakthroughs.Optical Coherence Tomography & Neurology
https://practicalneurology.com/diseases-diagnoses/imaging-testing/optical-coherence-tomography-neurology/31853/Going beyond the ophthalmoscope for multiple sclerosis, neuromyelitis optica spectrum disorder, and “microscopic Hollenhorst plaques.”Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Genetic Mechanisms of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-mechanisms-of-epilepsy/31588/Understanding gene and protein functions can sometimes guide diagnosis and treatment.